• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Thrombin activation and liver inflammation in advanced hepatitis C virus infection.晚期丙型肝炎病毒感染中的凝血酶激活与肝脏炎症
World J Gastroenterol. 2016 May 14;22(18):4427-37. doi: 10.3748/wjg.v22.i18.4427.
2
Hepatitis C Virus-Infected Apoptotic Hepatocytes Program Macrophages and Hepatic Stellate Cells for Liver Inflammation and Fibrosis Development: Role of Ethanol as a Second Hit.丙型肝炎病毒感染的凋亡肝细胞可对巨噬细胞和肝星状细胞进行编程,促进肝脏炎症和纤维化的发展:乙醇作为二次打击的作用。
Biomolecules. 2018 Oct 13;8(4):113. doi: 10.3390/biom8040113.
3
Parenchymal extinction: coagulation and hepatic fibrogenesis.实质消退:凝血与肝纤维化形成。
Clin Liver Dis. 2009 Feb;13(1):117-126. doi: 10.1016/j.cld.2008.09.013.
4
Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosis.伴有和不伴有门静脉血栓形成的肝硬化患者的血清网膜素和内脏脂肪素水平
World J Gastroenterol. 2017 Apr 14;23(14):2613-2624. doi: 10.3748/wjg.v23.i14.2613.
5
Understanding the Mechanisms of Fibrogenesis in HIV/HCV-Coinfected Patients: Implications for Clinical Practice.了解HIV/HCV合并感染患者的纤维化形成机制:对临床实践的启示。
AIDS Rev. 2015 Jul-Sep;17(3):159-70.
6
Coagulation and fibrosis in chronic liver disease.慢性肝病中的凝血与纤维化
Gut. 2008 Dec;57(12):1722-7. doi: 10.1136/gut.2008.150748.
7
Pathological process of liver sinusoidal endothelial cells in liver diseases.肝脏疾病中肝窦内皮细胞的病理过程。
World J Gastroenterol. 2017 Nov 21;23(43):7666-7677. doi: 10.3748/wjg.v23.i43.7666.
8
Toll-like receptor-4 expression by hepatic progenitor cells and biliary epithelial cells in HCV-related chronic liver disease.肝祖细胞和胆管上皮细胞中 Toll 样受体 4 的表达与 HCV 相关的慢性肝病。
Mod Pathol. 2012 Apr;25(4):576-89. doi: 10.1038/modpathol.2011.197. Epub 2011 Dec 16.
9
New Mechanism of Hepatic Fibrogenesis: Hepatitis C Virus Infection Induces Transforming Growth Factor β1 Production through Glucose-Regulated Protein 94.肝纤维化形成的新机制:丙型肝炎病毒感染通过葡萄糖调节蛋白94诱导转化生长因子β1产生
J Virol. 2015 Dec 30;90(6):3044-55. doi: 10.1128/JVI.02976-15.
10
Mechanisms Underlying Hepatitis C Virus-Associated Hepatic Fibrosis.丙型肝炎病毒相关肝纤维化的发病机制。
Cells. 2019 Oct 14;8(10):1249. doi: 10.3390/cells8101249.

引用本文的文献

1
Mechanistic Insights into the Role of MCP-1 in Diverse Liver Pathological Conditions: A Recent Update.MCP-1在多种肝脏病理状况中的作用的机制性见解:最新进展
Curr Pharm Des. 2025 Mar 3;31(15):1167-1179. doi: 10.2174/0113816128332969241120030733.
2
Correlation Between Thrombin Generation and Hepatic Fibrosis in Chronic Liver Diseases.慢性肝病中凝血酶生成与肝纤维化的相关性
Cureus. 2024 Oct 13;16(10):e71376. doi: 10.7759/cureus.71376. eCollection 2024 Oct.
3
Hepatitis C virus infection and Parkinson's disease: insights from a joint sex-stratified BioOptimatics meta-analysis.丙型肝炎病毒感染与帕金森病:来自联合性别分层 BioOptimatics 荟萃分析的新见解。
Sci Rep. 2024 Oct 1;14(1):22838. doi: 10.1038/s41598-024-73535-0.
4
Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response.直接抗病毒药物治疗对丙型肝炎病毒相关肝硬化和持续病毒学应答患者凝血参数的影响。
Medicina (Kaunas). 2024 Sep 20;60(9):1539. doi: 10.3390/medicina60091539.
5
Interaction between coagulation and inflammatory system in liver disease: re-focus on hematological markers.肝脏疾病中凝血和炎症系统的相互作用:重新关注血液学标志物。
Biomark Med. 2024;18(19):813-822. doi: 10.1080/17520363.2024.2395245. Epub 2024 Sep 4.
6
Hepatic microcirculatory disturbance in liver diseases: intervention with traditional Chinese medicine.肝脏疾病中的肝微循环障碍:中医药干预
Front Pharmacol. 2024 Jul 23;15:1399598. doi: 10.3389/fphar.2024.1399598. eCollection 2024.
7
The association between hepatitis C virus infection status and blood pressure in adults in the United States: NHANES 1999-2012.美国成年人丙型肝炎病毒感染状况与血压的关系:NHANES 1999-2012。
Front Cell Infect Microbiol. 2024 Jun 4;14:1401323. doi: 10.3389/fcimb.2024.1401323. eCollection 2024.
8
A Review on The Pathogenesis of Cardiovascular Disease of Viruses Infection.病毒感染致心血管疾病发病机制的研究进展
Viruses. 2024 Feb 27;16(3):365. doi: 10.3390/v16030365.
9
Plasma Pattern of Extracellular Vesicles Isolated from Hepatitis C Virus Patients and Their Effects on Human Vascular Endothelial Cells.从丙型肝炎病毒患者中分离出的细胞外囊泡的血浆模式及其对人血管内皮细胞的影响。
Int J Mol Sci. 2023 Jun 15;24(12):10197. doi: 10.3390/ijms241210197.
10
A Machine Learning Framework for Assessing the Risk of Venous Thromboembolism in Patients Undergoing Hip or Knee Replacement.一种用于评估髋关节或膝关节置换患者静脉血栓栓塞风险的机器学习框架。
J Healthc Inform Res. 2022 Oct 25;6(4):423-441. doi: 10.1007/s41666-022-00121-2. eCollection 2022 Dec.

本文引用的文献

1
The M358R variant of α(1)-proteinase inhibitor inhibits coagulation factor VIIa.α(1)-蛋白酶抑制剂的M358R变体可抑制凝血因子VIIa。
Biochem Biophys Res Commun. 2016 Feb 12;470(3):710-713. doi: 10.1016/j.bbrc.2016.01.069. Epub 2016 Jan 13.
2
Antithrombin: anti-inflammatory properties and clinical applications.抗凝血酶:抗炎特性及临床应用
Thromb Haemost. 2016 Apr;115(4):712-28. doi: 10.1160/TH15-08-0687. Epub 2015 Dec 17.
3
Tissue Factor Pathway Inhibitor: Multiple Anticoagulant Activities for a Single Protein.组织因子途径抑制剂:单一蛋白质的多种抗凝活性。
Arterioscler Thromb Vasc Biol. 2016 Jan;36(1):9-14. doi: 10.1161/ATVBAHA.115.305996. Epub 2015 Nov 24.
4
Hepatitis C Virus Infection Associated With an Increased Risk of Deep Vein Thrombosis: A Population-Based Cohort Study.丙型肝炎病毒感染与深静脉血栓形成风险增加相关:一项基于人群的队列研究。
Medicine (Baltimore). 2015 Sep;94(38):e1585. doi: 10.1097/MD.0000000000001585.
5
Thrombosis Associated with Viral Hepatitis.血栓形成与病毒性肝炎相关。
J Clin Transl Hepatol. 2014 Dec;2(4):234-9. doi: 10.14218/JCTH.2014.00031. Epub 2014 Dec 15.
6
Hemostasis abnormalities in cirrhosis.肝硬化中的止血异常。
Curr Opin Hematol. 2015 Sep;22(5):406-12. doi: 10.1097/MOH.0000000000000164.
7
The Fibrinolytic Status in Liver Diseases.肝脏疾病中的纤维蛋白溶解状态。
Semin Thromb Hemost. 2015 Jul;41(5):474-80. doi: 10.1055/s-0035-1550437. Epub 2015 Jun 6.
8
A matched cross-sectional study of the association between circulating tissue factor activity, immune activation and advanced liver fibrosis in hepatitis C infection.一项关于丙型肝炎感染中循环组织因子活性、免疫激活与晚期肝纤维化之间关联的配对横断面研究。
BMC Infect Dis. 2015 Apr 17;15:190. doi: 10.1186/s12879-015-0920-1.
9
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.肝动脉血管舒张在肝硬化早期独立于门静脉高压。
PLoS One. 2015 Mar 20;10(3):e0121229. doi: 10.1371/journal.pone.0121229. eCollection 2015.
10
Factors associated with the platelet count in patients with chronic hepatitis C.慢性丙型肝炎患者血小板计数的相关因素
Thromb Res. 2015 May;135(5):823-8. doi: 10.1016/j.thromres.2015.02.010. Epub 2015 Feb 19.

晚期丙型肝炎病毒感染中的凝血酶激活与肝脏炎症

Thrombin activation and liver inflammation in advanced hepatitis C virus infection.

作者信息

González-Reimers Emilio, Quintero-Platt Geraldine, Martín-González Candelaria, Pérez-Hernández Onán, Romero-Acevedo Lucía, Santolaria-Fernández Francisco

机构信息

Emilio González-Reimers, Geraldine Quintero-Platt, Candelaria Martín-González, Onán Pérez-Hernández, Lucía Romero-Acevedo, Francisco Santolaria-Fernández, Servicio de Medicina Interna, Hospital Universitario de Canarias, Universidad de La Laguna, Tenerife, 38320 Canary Islands, Spain.

出版信息

World J Gastroenterol. 2016 May 14;22(18):4427-37. doi: 10.3748/wjg.v22.i18.4427.

DOI:10.3748/wjg.v22.i18.4427
PMID:27182154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4858626/
Abstract

Hepatitis C virus (HCV) infection is associated with increased thrombotic risk. Several mechanisms are involved including direct endothelial damage by the HCV virus, with activation of tissue factor, altered fibrinolysis and increased platelet aggregation and activation. In advanced stages, chronic HCV infection may evolve to liver cirrhosis, a condition in which alterations in the portal microcirculation may also ultimately lead to thrombin activation, platelet aggregation, and clot formation. Therefore in advanced HCV liver disease there is an increased prevalence of thrombotic phenomena in portal vein radicles. Increased thrombin formation may activate hepatic stellate cells and promote liver fibrosis. In addition, ischemic changes derived from vascular occlusion by microthrombi favor the so called parenchymal extinction, a process that promotes collapse of hepatocytes and the formation of gross fibrous tracts. These reasons may explain why advanced HCV infection may evolve more rapidly to end-stage liver disease than other forms of cirrhosis.

摘要

丙型肝炎病毒(HCV)感染与血栓形成风险增加有关。涉及多种机制,包括HCV病毒对内皮细胞的直接损伤,伴有组织因子激活、纤维蛋白溶解改变以及血小板聚集和激活增加。在晚期,慢性HCV感染可能发展为肝硬化,在这种情况下,门静脉微循环的改变最终也可能导致凝血酶激活、血小板聚集和血栓形成。因此,在晚期HCV肝病中,门静脉分支血栓形成现象的发生率增加。凝血酶形成增加可能激活肝星状细胞并促进肝纤维化。此外,微血栓导致的血管闭塞引起的缺血性改变有利于所谓的实质细胞消亡,这一过程促进肝细胞塌陷和粗大纤维束的形成。这些原因可能解释了为什么晚期HCV感染比其他形式的肝硬化更易迅速发展为终末期肝病。